MedPath

The changes in visual function after intravitreal bevacizmab for ocular neovascular diseases

Not Applicable
Recruiting
Conditions
Ocular neovascular diseases
Registration Number
JPRN-UMIN000021074
Lead Sponsor
Ophthalmology, Kagoshima university
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Ocular non-neovascular diseases

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Visual acuity and Activity of ocular neovascularization for 24 months after injection
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath